BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 33746442)

  • 1. A Nationwide Analysis of Budd-Chiari Syndrome in the United States.
    Alukal JJ; Zhang T; Thuluvath PJ
    J Clin Exp Hepatol; 2021; 11(2):181-187. PubMed ID: 33746442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of prothrombotic factors in patients with Budd-Chiari syndrome or non-cirrhotic nonmalignant portal vein thrombosis: A hospital-based observational study.
    Fan J; Wang Q; Luo B; Chen H; Wang Z; Niu J; Yuan J; Yuan X; Bai W; He C; Guo W; Li K; Yin Z; Fan D; Han G
    J Gastroenterol Hepatol; 2020 Jul; 35(7):1215-1222. PubMed ID: 31711259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Budd-Chiari syndrome following laparoscopic cholecystectomy.
    Amarapurkar PD; Parekh SJ; Sundeep P; Amarapurkar DN
    J Clin Exp Hepatol; 2013 Sep; 3(3):256-9. PubMed ID: 25755508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombophilic dimension of Budd chiari syndrome and portal venous thrombosis--a concise review.
    Shetty S; Ghosh K
    Thromb Res; 2011 Jun; 127(6):505-12. PubMed ID: 20961602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Budd-Chiari syndrome: a common complication of Behçet's disease.
    Bayraktar Y; Balkanci F; Bayraktar M; Calguneri M
    Am J Gastroenterol; 1997 May; 92(5):858-62. PubMed ID: 9149201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mortality and health care burden of Budd Chiari syndrome in the United States: A nationwide analysis (1998-2017).
    Alukal JJ; Zhang T; Thuluvath PJ
    World J Hepatol; 2021 Jun; 13(6):686-698. PubMed ID: 34239703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Redefining Budd-Chiari syndrome: A systematic review.
    Shin N; Kim YH; Xu H; Shi HB; Zhang QQ; Colon Pons JP; Kim D; Xu Y; Wu FY; Han S; Lee BB; Li LS
    World J Hepatol; 2016 Jun; 8(16):691-702. PubMed ID: 27326316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic outflow obstruction (Budd-Chiari syndrome). Experience with 177 patients and a review of the literature.
    Dilawari JB; Bambery P; Chawla Y; Kaur U; Bhusnurmath SR; Malhotra HS; Sood GK; Mitra SK; Khanna SK; Walia BS
    Medicine (Baltimore); 1994 Jan; 73(1):21-36. PubMed ID: 8309360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fulminant Budd-Chiari syndrome associated with polycythemia rubra vera and factor V Leiden mutation.
    Akyildiz M; Karasu Z; Dheir H; Osmanoglu N; Akay S; Ilter T
    Eur J Intern Med; 2006 Jan; 17(1):66-7. PubMed ID: 16378893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and risk factors of hepatocellular carcinoma in Budd-Chiari syndrome: a systematic review.
    Ren W; Qi X; Yang Z; Han G; Fan D
    Eur J Gastroenterol Hepatol; 2013 Jul; 25(7):830-41. PubMed ID: 23411869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aetiological factors of Budd-Chiari syndrome in Algeria.
    Afredj N; Guessab N; Nani A; Faraoun SA; Ouled Cheikh I; Kerbouche R; Hannoun D; Amir ZC; Ait Kaci H; Bentabak K; Plessier A; Valla DC; Cazals-Hatem V; Denninger MH; Boucekkine T; Debzi N
    World J Hepatol; 2015 Apr; 7(6):903-9. PubMed ID: 25937867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Budd-Chiari syndrome/hepatic venous outflow tract obstruction.
    Valla DC
    Hepatol Int; 2018 Feb; 12(Suppl 1):168-180. PubMed ID: 28685257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relationship between the levels and function of endothelial progenitor cells and factor V Leiden and protein C deficiency in patients with primary Budd-Chiari syndrome.
    Guan ZY; Yu CW; Song T; Gao Y
    Eur Rev Med Pharmacol Sci; 2018 May; 22(9):2742-2750. PubMed ID: 29771426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Etiology based prevalence of Budd-Chiari syndrome in eastern India.
    De BK; De KK; Sen S; Biswas PK; Das TK; Das S; Hazra B
    J Assoc Physicians India; 2000 Aug; 48(8):800-3. PubMed ID: 11273472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proposal of a new nomenclature for Budd-Chiari syndrome: hepatic vein thrombosis versus thrombosis of the inferior vena cava at its hepatic portion.
    Okuda K; Kage M; Shrestha SM
    Hepatology; 1998 Nov; 28(5):1191-8. PubMed ID: 9794901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for and causes and treatment of recurrence of inferior vena cava type of Budd-Chiari syndrome after stenting in China: A retrospective analysis of a large cohort.
    Li WD; Yu HY; Qian AM; Rong JJ; Zhang YQ; Li XQ
    Eur Radiol; 2017 Mar; 27(3):1227-1237. PubMed ID: 27387875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Oral contraceptives and blood diseases are the most common causes of Budd-Chiari syndrome].
    Almer S; Bodemar G; Rydén BO; Elfström J; Franzén L; Ihse I; Resjö M
    Lakartidningen; 1989 Nov; 86(46):4002-8. PubMed ID: 2511387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Review article: a multidisciplinary approach to the diagnosis and management of Budd-Chiari syndrome.
    Khan F; Armstrong MJ; Mehrzad H; Chen F; Neil D; Brown R; Cain O; Tripathi D
    Aliment Pharmacol Ther; 2019 Apr; 49(7):840-863. PubMed ID: 30828850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Budd-Chiari Syndrome Imaging Diagnosis: State of the Art and Future Perspectives.
    Porrello G; Mamone G; Miraglia R
    Diagnostics (Basel); 2023 Jul; 13(13):. PubMed ID: 37443650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PAI-1 4G-4G, MTHFR 677TT, V Leiden 506Q, and Prothrombin 20210A in Splanchnic Vein Thrombosis: Analysis of Individual Patient Data From Three Prospective Studies.
    Pasta L; Pasta F; D'Amico M
    J Clin Exp Hepatol; 2016 Mar; 6(1):10-4. PubMed ID: 27194890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.